Scholars Central

Conference abstractPublished 8 Apr 2019

Modelling neuro developmental disorders in a dish

Authors: Hilde Van Esch, Cedric Thues, Savitha Nageshappa, Mala Isrie, Catherine Verfaillie, Liesbeth Deaulmerie, Nils Schoovaerts, Patrik Verstreken, Cassiano Carromeu, Alysson Muotri

Katholieke Universiteit Leuven, Belgium VIB Center for the Biology of Disease, Belgium University of California San Diego, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The leading manifestation of brain dysfunction is intellectual disability, affecting approximately 3% of the general population. Given the uniqueness and the complexity of human cognition and behavior, studies in humans are essential to understand the role of the multitude of genes involved in these processes. We previously developed IPSC from patients with MECP2 duplication syndrome carrying different duplication sizes, to study the impact of increased MePC2 dosage in human neurons. MECP2 duplication syndrome is a severe neurodevelopmental disorder in males, characterized by severe neurodevelopmental delay with onset at birth, limited or absent speech, hypotonia, epilepsy, autism and motor dysfunction. Cortical neurons derived from Mecp 2dup-iPSCs had more synapses and altered network synchronization as well as dendritic complexity. Next, we tested a series of epigenetic drugs for the ability to rescue neuronal defects and validated two HDAC inhibitors as potential clinical candidates. We are currently developing an iPSC model for a novel tubulinopathy, characterized by intellectual disability associated with characteristic dysmorphic signs: circumferential skin creases, cleft palate, facial dysmorphisms and short stature. This developmental disorder is caused by mutations in a novel gene, MAPRE2 (Microtubule-Associated Protein Member 2) encoding a member of the EB family. We derived patient-specific induced Pluripotent Stem Cell (iPSC) and established isogenic rescue lines as well as patient specific knock-in lines using CRISPR/CAS9. These iPSCâ??s are then differentiated towards Neural Progenitor Cells (NPC), cortical neurons and Cranial Neural Crest Cells (CNCC) using adapted and optimized differentiation protocols. Preliminary functional experiments using patient fibroblasts showed an increase in migration speed and overall mitosis duration. We will now perform similar experiments to analyze the mitosis and migration rate of iPSC derived NPCâ??s and CNCCâ??s. In addition a full morphological work-up is ongoing. We will present these novel data at the meeting.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Molecular and Genetic Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Hilde Van Esch”
  • BylineArticles whose byline prints “Cedric Thues”
  • BylineArticles whose byline prints “Savitha Nageshappa”
  • BylineArticles whose byline prints “Mala Isrie”
  • BylineArticles whose byline prints “Catherine Verfaillie”
  • BylineArticles whose byline prints “Liesbeth Deaulmerie”
  • BylineArticles whose byline prints “Nils Schoovaerts”
  • BylineArticles whose byline prints “Patrik Verstreken”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels